Valuation dashboard for NanoVibronix, Inc. (NAOV) with P/E N/A, P/B 0.38, EV/EBITDA -2.96 and dividend yield 0.00%. DCF, Graham Number and Earnings Power Value models plus sector comparison against other Healthcare companies.
NanoVibronix, Inc., operating through its subsidiary NanoVibronix Ltd., develops and commercializes innovative, non-invasive devices that stimulate biological responses for therapeutic purposes. Their core focus areas include mitigating biofilm formation, accelerating wound repair, and alleviating pain.
Analysis Summary
NanoVibronix, Inc. reported revenue of $2.6M in the most recent fiscal year, growing at a 5-year CAGR of 32.6%.
Trailing-twelve-month margins: gross margin -26.1%, operating margin -13.6%, net margin -12.6%.
At the current price of $1.90, NAOV has negative trailing earnings (P/E not meaningful) and an ROE of -54.29%. Market capitalisation stands at $2M.
Balance sheet quality for NAOV: current ratio of 1.1. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| Price / Book | 0.38 |
| EV / EBITDA | -2.96 |
| Dividend Yield | 0.00% |
Valuation Models
| DCF Fair Value | $-109.85 |
| vs Current Price | -5881.4% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| NAOV | NanoVibronix, Inc. | $2M | 0.38 | -54.3% | |
| ABT | Abbott Laboratories | $177.1B | 32.49 | 3.45 | 10.5% |
| 0Y6X.L | Medtronic Plc | $125.7B | |||
| MDT | Medtronic plc | $118.5B | 22.97 | 2.39 | 10.6% |
| SYK | Stryker Corporation | $109.2B | 29.95 | 4.66 | 16.4% |
| 0R2S.L | Stryker Corporation | $107.9B | 29.27 | 4.55 | 16.4% |
| 0HOY.L | Boston Scientific Corporation | $66.5B | 48.91 | 5.86 | 11.9% |
| BSX | Boston Scientific Corporation | $65.3B | 17.73 | 2.61 | 14.9% |
Price
| Price | $1.90 |
| Market Cap | $2M |
| Exchange | NASDAQ |
| Country | US |
Profitability
| Return on Equity | -54.29% |
| Return on Invested Capital | -65.14% |
| Return on Assets | -44.22% |
| Gross Margin | -26.06% |
| Operating Margin | -1362.72% |
| Net Margin | -1259.55% |
Related companies: ACON · AMIX · BBLG · BJDX · CNSP · GRI · HSCS
Explore sector: Healthcare · Medical - Devices
More sections of NAOV: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks